EVANGELISTA, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.855
AS - Asia 6.096
EU - Europa 3.766
SA - Sud America 1.724
AF - Africa 1.659
OC - Oceania 175
Continente sconosciuto - Info sul continente non disponibili 89
Totale 23.364
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.978
HK - Hong Kong 1.539
SG - Singapore 1.255
BR - Brasile 1.137
CN - Cina 989
IT - Italia 591
VN - Vietnam 564
PL - Polonia 375
FR - Francia 291
RU - Federazione Russa 288
FI - Finlandia 276
DE - Germania 256
AR - Argentina 113
NL - Olanda 101
SE - Svezia 94
GB - Regno Unito 87
IE - Irlanda 87
AT - Austria 86
KR - Corea 82
UA - Ucraina 82
IN - India 77
MX - Messico 75
IQ - Iraq 70
KG - Kirghizistan 67
UZ - Uzbekistan 67
ZA - Sudafrica 67
TR - Turchia 65
ID - Indonesia 64
EC - Ecuador 63
CO - Colombia 62
SA - Arabia Saudita 61
HN - Honduras 60
IR - Iran 60
PE - Perù 59
TH - Thailandia 58
AM - Armenia 57
CH - Svizzera 57
SN - Senegal 57
KZ - Kazakistan 56
NI - Nicaragua 56
AO - Angola 55
CI - Costa d'Avorio 54
DO - Repubblica Dominicana 54
PK - Pakistan 54
VE - Venezuela 54
DZ - Algeria 53
TN - Tunisia 53
UY - Uruguay 53
ES - Italia 52
KE - Kenya 52
GR - Grecia 51
YE - Yemen 51
TJ - Tagikistan 50
BE - Belgio 49
BO - Bolivia 49
EE - Estonia 49
EG - Egitto 49
HR - Croazia 49
JP - Giappone 49
PY - Paraguay 49
BG - Bulgaria 48
CR - Costa Rica 48
CZ - Repubblica Ceca 48
IS - Islanda 48
LV - Lettonia 48
PA - Panama 48
PT - Portogallo 48
BA - Bosnia-Erzegovina 47
CW - ???statistics.table.value.countryCode.CW??? 47
PR - Porto Rico 47
YT - Mayotte 47
AE - Emirati Arabi Uniti 46
BY - Bielorussia 46
CL - Cile 46
PH - Filippine 46
AL - Albania 45
BZ - Belize 45
MD - Moldavia 45
MY - Malesia 45
PS - Palestinian Territory 45
CV - Capo Verde 44
DJ - Gibuti 44
HU - Ungheria 44
SI - Slovenia 44
CU - Cuba 43
GT - Guatemala 43
JO - Giordania 43
LY - Libia 43
MG - Madagascar 43
NO - Norvegia 43
AZ - Azerbaigian 42
IL - Israele 42
LA - Repubblica Popolare Democratica del Laos 42
RO - Romania 42
RS - Serbia 42
ZW - Zimbabwe 42
BD - Bangladesh 41
CM - Camerun 41
GH - Ghana 41
LB - Libano 41
Totale 21.341
Salva come PNG Salva come JPEG
Città #
Fairfield 1.604
Hong Kong 1.493
Ashburn 888
Singapore 810
Woodbridge 695
Houston 606
Seattle 580
Cambridge 544
Wilmington 436
Boardman 363
Medford 335
Princeton 334
Bytom 316
Chandler 313
Beijing 272
Des Moines 263
Dong Ket 261
Ann Arbor 232
Helsinki 226
San Diego 220
Santa Clara 156
Ho Chi Minh City 112
Roxbury 96
São Paulo 90
Jinan 89
Dublin 78
Munich 71
Padova 70
Hefei 63
Hanoi 61
Nanjing 61
Tashkent 61
Bishkek 60
Dakar 56
Rome 56
Nuremberg 55
Managua 54
Montevideo 50
Dushanbe 49
Los Angeles 49
Luanda 49
Abidjan 48
Yerevan 47
Seoul 45
Vienna 45
Panama City 44
Nairobi 43
Amman 42
Baku 41
Ulan Bator 41
Antananarivo 40
Bridgetown 40
Castries 40
Riga 40
Nassau 39
Shenyang 39
Djibouti 38
Harare 38
Havana 38
Milan 38
Sanaa 38
Willemstad 38
Accra 37
Libreville 37
Lusaka 37
Andorra la Vella 36
Bamako 36
Chicago 36
San José 36
Tallinn 36
Conakry 35
Vientiane 35
Guangzhou 34
Niamey 34
Phnom Penh 34
Praia 34
Zhengzhou 34
Podgorica 33
Addis Ababa 32
Chisinau 32
Cotonou 32
Lima 32
Noumea 32
San Pedro Sula 32
Kingstown 31
Nanchang 31
Nouakchott 31
Dili 30
Kinshasa 30
Dar es Salaam 29
Haikou 29
Mamoudzou 29
Minsk 29
Ouagadougou 29
Sofia 29
Tunis 29
Kampala 28
Reykjavik 28
Athens 27
Guatemala City 27
Totale 14.361
Salva come PNG Salva come JPEG
Nome #
10-Year Clinical Experience with 18F-Choline PET/CT: An Italian Multicenter Retrospective Assessment of 3343 Patients 220
Nuovi radiofarmaci per diagnosi e terapia: il rame 64 186
18F-FDG PET/CT and urothelial carcinoma: Impact on management and prognosis—a multicenter retrospective study 181
PET/MRI in prostate cancer: a systematic review and meta-analysis 177
18F-choline PET/CT and PET/MRI in primary and recurrent hyperparathyroidism: a systematic review of the literature 163
[18F]FDG PET/MRI in rectal cancer 157
MP79-02 EVALUATION OF THE PROGNOSTIC IMPACT OF 18F-CHOLINE PET/CT IN PATIENTS WITH SKELETAL RECURRENCE PROSTATE CANCER 148
The role of 18f-fdg pet/ct in staging and prognostication of mantle cell lymphoma: An italian multicentric study 146
Comparison between18F-Dopa and 18F-Fet PET/CT in patients with suspicious recurrent high grade glioma: A literature review and our experience 139
Could semiquantitative FDG analysis add information to the prognosis in patients with stage II/III breast cancer undergoing neoadjuvant treatment? 138
18 F-Choline PET/CT in Leptomeningeal Breast Cancer Metastases 138
PET/MR in recurrent glioblastoma patients treated with regorafenib: [18F]FET and DWI-ADC for response assessment and survival prediction 138
Radiolabelled choline and FDG PET/CT: two alternatives for the assessment of lymph node metastases in patients with upper urinary tract urothelial carcinoma 137
State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation 134
68Ga-dotatoc vs.18F-FDG vs. radiolabelled PSMA PET/CT in renal cancer patients 128
Microdosimetric measurements in the thermal neutron irradiation facility of LENA reactor 127
A Solitary Metastasis for a Malignant Schwannoma in the Gallbladder Detected by 18F-FDG PET/CT 127
THE WAR IS OPENED: PSMA VS. 64CuCL2 VS. CHOLINE PET/CT 126
Re: Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis, et al. Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomized, Multicenter Study. Lancet 2020;395:1208–16 126
Targeting prostate cancer with the anti-PSMA scFvD2B: a theranostic promise for nuclear medicine 122
18F-FDG PET/MRI in adult sarcomas 121
Diagnostic and prognostic impact of fluorine-18-fluorodeoxyglucose PET/CT in preoperative and postoperative setting of breast cancer patients 119
18F-DOPA and 18F-FDG PET/CT, scintigraphic localization and radioguided surgery of recurrent medullary thyroid cancer: two case reports 119
64CuCl2 PET/CT in a hyperfunctioning parathyroid gland 116
Diagnostic imaging to detect and evaluate response to therapy in bone metastases from prostate cancer: current modalities and new horizons 113
Novel Nuclear Medicine Imaging Applications in Immuno-Oncology 113
An Incidental Uptake of 18F-Choline at PET/CT in Gastric Neuroendocrine Tumor 112
Suspicious for recurrent low and high grade glioma and indeterminate MRI: the role of 18F-DOPA PET/CT 110
Molecular Imaging of Pulmonary Inflammation and Infection 109
18F-FDG or 68Ga/18F-PSMA PET/CT in recurrent renal cancer? 108
Utility of Choline Positron Emission Tomography/Computed Tomography for Lymph Node Involvement Identification in Intermediate- to High-risk Prostate Cancer: A Systematic Literature Review and Meta-analysis. 107
FDG PET/MRI in the follow-up of hepatocellular carcinoma after liver transplantation 105
A Prospective Randomized Multicenter Study on the Impact of [18F]F-Choline PET/CT Versus Conventional Imaging for Staging Intermediate- to High-Risk Prostate Cancer 105
The effects of androgen deprivation therapy on the 18F-choline uptake in prostate cancer patients undergoing neoadjuvant treatment 103
Ga-68 DOTA-peptides and F-18 FDG PET/CT in patients with neuroendocrine tumor: A review 103
Comparison of MRI, PET, and 18F-choline PET/MRI in patients with oligometastatic recurrent prostate cancer 103
Predictive and prognostic value of 18F-DOPA PET/CT in patients affected by recurrent medullary carcinoma of the thyroid 102
FDG avidity at PET/CT during adjuvant hormonal therapy in patients with breast cancer 101
Diagnostic and prognostic value of 18F-FDG PET/CT in recurrent germinal tumor carcinoma 101
Is radiocholine PET/CT already clinically useful in patients with prostate cancer? 101
The Future of Choline PET in the Era of Prostate Specific Membrane Antigen 101
PET/CT And The Response To Immunotherapy In Lung Cancer 101
Role of molecular imaging in the management of patients affected by inflammatory bowel disease: State-of-the-art 100
18F-DOPA and 18F-FDG PET/CT, scintigraphic localization and radioguided surgery of recurrent medullary thyroid cancer: two case reports 100
Biochemical and Pathophysiological Premises to Positron Emission Tomography With Choline Radiotracers 100
Performance of FDG-PET/CT in solitary pulmonary nodule based on pre-test likelihood of malignancy: results from the ITALIAN retrospective multicenter trial 100
Immunotherapy and 18F-FDG PET/CT: standardised procedures are needed 100
Prostate cancer imaging: when the game gets tough, the hard one gets done! 99
18F-DOPA and 18F-FDG PET/CT, scintigraphic localization and radioguided surgery of recurrent medullary thyroid cancer: two case reports 99
C-reactive protein levels are associated with paraoxonase polymorphism L55M in patients undergoing cardiac SPECT imaging 98
Follow-up of patients with early breast cancer: is it time to rewrite the story? 98
Management of hyperglycemia in oncological patients scheduled for an FDG-PET/CT examination 98
The bone pathway: 223Ra-dichloride 95
Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 2 95
Early detection of prostate cancer relapse by biochemistry and diagnostic imaging 95
GUIDELINES ON RADIOISOTOPE TREATMENT OF LIVER CANCER AND LIVER METASTASES WITH INTRA-ARTERIAL RADIOACTIVE COMPOUNDS 94
New Clinical Indications for 18F/11C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature [Figure presented] 94
Bone metastases from prostate cancer: Biology, diagnosis and management 94
Tumour markers and FDG PET/CT for prediction of disease relapse in patients with breast cancer 93
Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 1 93
Tumor Immune-Infiltrate Landscape After Chemo-Radiotherapy in a Case Series of Patients with Non-small Cell Lung Cancer: Pretreatment Predictors and Correlation With Outcome 92
The Overall Survival and Progression-Free Survival in Patients with Advanced Adrenocortical Cancer Is Increased after the Multidisciplinary Team Evaluation 92
GUIDELINES ON RADIOISOTOPE TREATMENT OF LYMPHOMAS 92
The role of FDG PET/CT or PET/MRI in assessing response to neoadjuvant therapy for patients with borderline or resectable pancreatic cancer: a systematic literature review 92
Translational molecular imaging in exocrine pancreatic cancer 91
The multicenter ITALIAN trial assess the performance of FDG-PET/CT related to pre-test cancer risk in patients with solitary pulmonary nodules and introduces a segmental thoracic diagnostic strategy 91
Targeted therapy with Radium-223 of bone metastases 90
Cardiovascular risk stratification of diabetic patients 90
Usefulness of stress cardiac single-photon emission computed tomographic imaging late after percutaneous coronary intervention for assessing cardiac events and time to such events 89
Role of radiomic analysis of [18F]fluoromethylcholine PET/CT in predicting biochemical recurrence in a cohort of intermediate and high risk prostate cancer patients at initial staging 88
From Bottleneck to Enabler: A New Approach to Regulating Data-Driven Medical Research 88
MUNES: a MUltidisciplinar Neutron Source for BNCT and Nuclear Waste characterization 88
GUIDELINES ON RADIOISOTOPE TREATMENT OF NEUROENDOCRINE TUMORS 88
Approaches for Assessment of Response of Bone Metastases to Therapies 88
PET/CT imaging in gynecologic malignancies: A critical overview of its clinical impact and our retrospective single center analysis 88
Pet and spect imaging in the SARS-CoV-2 pandemic 88
Somatostatin Receptor PET/CT Imaging for the Detection and Staging of Pancreatic NET: A Systematic Review and Meta-Analysis 88
The ability of 18F-choline PET/CT to identify local recurrence of prostate cancer 87
Mismatch between perfusion and metabolism in locally advanced breast cancer 86
Diagnostic and Prognostic Value of 18F-FDG PET/CT in Male Breast Cancer: Results From a Bicentric Population 86
Discordance rate between radiolabelled choline PET/CT and bone scintigraphy in detecting bone metastases in patients with prostate cancer: a meta-analysis 86
Can FDG PET/CT monitor the response to hormonal therapy in breast cancer patients? 86
Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma: an Italian multicenter study 86
Estimation of coronary flow reserve by sestamibi imaging in type 2 diabetic patients with normal coronary arteries 85
PET/MRI in prostate cancer: a systematic review and meta-analysis 84
Assessment of the risk and its temporal variation in patients undergoing stress cardiac SPECT imaging late after percutaneous coronary intervention . 83
Assessment of the risk and its temporal variation in patients undergoing stress cardiac spect imaging late after percutaneous coronary intervention 83
Risk-related 18F-FDG PET/CT and new diagnostic strategies in patients with solitary pulmonary nodule: the ITALIAN multicenter trial 83
Head-to-head comparison between 18F-FDG PET/CT and PET/MRI in breast cancer 83
Diagnostic and prognostic evaluation of fluorodeoxyglucose positron emission tomography/computed tomography and its correlation with serum cancer antigen-125 (CA125) in a large cohort of ovarian cancer patients 82
What are the best ways to reduce the false-positive rate of 18F-FDG PET/CT in patients with breast cancer? 82
Cardiac performance during exercise in hypertensive patients without ventricular hypertrophy 82
Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: A cost of illness study 82
Results From a Large, Multicenter, Retrospective Analysis On Radium223 Use in Metastatic Castration-resistant Prostate Cancer (mCRPC) in the Triveneto Italian Region 82
An incidental finding behind adrenal incidentaloma 82
Renal function assessment after embolization of vascular complications following partial nephrectomy 81
Relation between wall thickening on gated perfusion SPECT and functional recovery after coronary revascularization in patients with previous myocardial infarction 81
What is the role of imaging in cancers? 81
[18F]FDG PET/CT and PET/MR in Patients with Adrenal Lymphoma: A Systematic Review of Literature and a Collection of Cases 80
Interpretative reproducibility of cardiac stress imaging: direct comparison between dobutamine echocardiography and single photon emission computed tomography. 80
Totale 10.512
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.133
article - articoli 56.009
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.498
Totale 139.640
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.726 0 0 0 197 80 77 118 310 146 296 165 337
2021/20222.759 57 536 173 127 165 112 133 188 230 80 156 802
2022/20231.289 626 87 18 53 103 132 9 61 101 28 47 24
2023/2024993 27 101 70 81 65 78 85 35 31 39 114 267
2024/20255.549 24 246 311 102 587 96 279 438 422 345 1.142 1.557
2025/20268.074 620 2.348 3.621 1.485 0 0 0 0 0 0 0 0
Totale 23.740